---
figid: PMC4885545__cej-25-65-g002
figlink: /pmc/articles/PMC4885545/figure/F2/
number: Fig. 2
caption: Luteolin (Lut) modulates cancer cell cycle progression. Luteolin’s antiproliferative
  activity is attributed to its ability to inhibit IGF-1 activation, thus preventing
  the phosphorylation of the intracellular IRS-1 and its downstream targets. Furthermore,
  luteolin inhibits IGF-1-mediated PI3K/Akt activation by reducing the expression
  of ERα. Estradiol receptor triggers the PI3K/AKT pathway, mediating FKHR phosphorylation,
  which functionally associates with ERα and forms a FKHR–ERα complex. Inhibiting
  AKT activity reduces phosphorylation of its downstream targets, including p70S6K1,
  GSK-3β, and FKHR. Luteolin suppresses prostate cancer cell proliferation by downregulating
  AR expression. Phosphorylation of the cytoplasmic AR by MAPK and AKT enables AR
  to form dimers and enhances ARE. By contrast, luteolin upregulates the expression
  of PDEF, which acts as an androgen-independent transcriptional activator of the
  prostate-specific antigen promoter. AR, androgen receptor; ARE, androgen response
  element; ER, estrogen receptor; Erk, extracellular signal-regulated kinase; FKHR,
  forkhead transcription factor; FLT3, Fms-like tyrosine kinase 3; GSK-3β, glycogen
  synthase kinase-3β; IGF-1, insulin-like growth factor 1; IRS-1, insulin receptor
  substrate 1; ITD, internal tandem duplications; MAPK, mitogen-activated protein
  kinase; mTOR, mammalian target of rapamycin; PDEF, prostate-derived Ets factor;
  PSAP, prosaposin; TDK, tyrosine kinase domain.
pmcid: PMC4885545
papertitle: Molecular targets of luteolin in cancer.
reftext: Muobarak J. Tuorkey. Eur J Cancer Prev. 2016 Jan;25(1):65-76.
pmc_ranked_result_index: '31439'
pathway_score: 0.9485447
filename: cej-25-65-g002.jpg
figtitle: Luteolin (Lut) modulates cancer cell cycle progression
year: '2016'
organisms: Homo sapiens
ndex: b86470f9-def7-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4885545__cej-25-65-g002.html
  '@type': Dataset
  description: Luteolin (Lut) modulates cancer cell cycle progression. Luteolin’s
    antiproliferative activity is attributed to its ability to inhibit IGF-1 activation,
    thus preventing the phosphorylation of the intracellular IRS-1 and its downstream
    targets. Furthermore, luteolin inhibits IGF-1-mediated PI3K/Akt activation by
    reducing the expression of ERα. Estradiol receptor triggers the PI3K/AKT pathway,
    mediating FKHR phosphorylation, which functionally associates with ERα and forms
    a FKHR–ERα complex. Inhibiting AKT activity reduces phosphorylation of its downstream
    targets, including p70S6K1, GSK-3β, and FKHR. Luteolin suppresses prostate cancer
    cell proliferation by downregulating AR expression. Phosphorylation of the cytoplasmic
    AR by MAPK and AKT enables AR to form dimers and enhances ARE. By contrast, luteolin
    upregulates the expression of PDEF, which acts as an androgen-independent transcriptional
    activator of the prostate-specific antigen promoter. AR, androgen receptor; ARE,
    androgen response element; ER, estrogen receptor; Erk, extracellular signal-regulated
    kinase; FKHR, forkhead transcription factor; FLT3, Fms-like tyrosine kinase 3;
    GSK-3β, glycogen synthase kinase-3β; IGF-1, insulin-like growth factor 1; IRS-1,
    insulin receptor substrate 1; ITD, internal tandem duplications; MAPK, mitogen-activated
    protein kinase; mTOR, mammalian target of rapamycin; PDEF, prostate-derived Ets
    factor; PSAP, prosaposin; TDK, tyrosine kinase domain.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT7A
  - WNT7B
  - WNT8A
  - PSAP
  - MAP2K1
  - MAP2K2
  - MAPK9
  - MAPK10
  - MAPK13
  - WNT6
  - SPDEF
  - WNT10B
  - NRAS
  - MAPK12
  - MTOR
  - PIK3R5
  - AKT2
  - HRAS
  - ESR1
  - AKT1
  - PIK3CB
  - AR
  - WNT2B
  - MAPK1
  - WNT9B
  - WNT11
  - PIK3R4
  - WNT9A
  - MAPK8
  - MAPK11
  - MAPK3
  - PIK3CG
  - PIK3CD
  - KRAS
  - FOXO1
  - FLT3
  - PIK3CA
  - WNT8B
  - WNT16
  - AKT3
  - PIK3R6
  - WNT2
  - PIK3R3
  - WNT5A
  - GSK3B
  - IGF1
  - WNT10A
  - WNT1
  - MAPK14
  - WNT3
  - WNT4
  - WNT3A
  - IRS1
  - IGF1R
  - WNT5B
  - Cancer
genes:
- word: Wnt/B
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: Wnt/B
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: Wnt/B
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: PSAP
  symbol: PSAP
  source: hgnc_symbol
  hgnc_symbol: PSAP
  entrez: '5660'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: Wnt/B
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: PDEF
  symbol: PDEF
  source: hgnc_alias_symbol
  hgnc_symbol: SPDEF
  entrez: '25803'
- word: Wnt/B
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: P13K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: ERa
  symbol: ER-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: ESR1
  entrez: '2099'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: P13K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: AR
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
- word: Wnt/B
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: Erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Wnt/B
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: Wnt/B
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: P13K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: Wnt/B
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: P13K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: P13K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: FKHR
  symbol: FKHR
  source: hgnc_prev_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: FLT3
  symbol: FLT3
  source: hgnc_symbol
  hgnc_symbol: FLT3
  entrez: '2322'
- word: P13K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: Wnt/B
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: Wnt/B
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: P13K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Wnt/B
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: P13K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Wnt/B
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: GSK-3B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: IGF-1
  symbol: IGF1
  source: hgnc_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: Wnt/B
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: Wnt/B
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: Wnt/B
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: Wnt/B
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: Wnt/B
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: IRS-1
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: IGF-1R
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: Wnt/B
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
